| Visceral leishmaniasis: an overview of vaccine adjuvants and their applications S Ratnapriya, AA Sahasrabuddhe, A Dube Vaccine 37 (27), 3505-3519, 2019 | 44 | 2019 |
| Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis NK Yadav, S Joshi, S Ratnapriya, AA Sahasrabuddhe, A Dube Vaccine 36 (17), 2293-2299, 2018 | 16 | 2018 |
| Adjuvant‐mediated enhancement of the immune response to HIV vaccines S Ratnapriya, E Perez‐Greene, L Schifanella, A Herschhorn The FEBS Journal 289 (12), 3317-3334, 2022 | 15 | 2022 |
| Intra-and extra-cellular environments contribute to the fate of HIV-1 infection S Ratnapriya, M Harris, A Chov, ZT Herbert, V Vrbanac, M Deruaz, ... Cell reports 36 (9), 2021 | 14 | 2021 |
| A protocol for studying HIV-1 envelope glycoprotein function S Ratnapriya, A Chov, A Herschhorn STAR protocols 1 (3), 100133, 2020 | 13 | 2020 |
| Slow receptor binding of the noncytopathic HIV-2UC1 Envs is balanced by long-lived activation state and efficient fusion activity M Harris, S Ratnapriya, A Chov, H Cervera, A Block, C Gu, N Talledge, ... Cell reports 31 (10), 2020 | 12 | 2020 |
| A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1‐Inclined Immune Response against … S Ratnapriya, Keerti, NK Yadav, A Dube, AA Sahasrabuddhe BioMed Research International 2021 (1), 8845826, 2021 | 10 | 2021 |
| Changes in the V1 loop of HIV-1 envelope glycoproteins can allosterically modulate the trimer association domain and reduce PGT145 sensitivity H Cervera, S Ratnapriya, A Chov, A Herschhorn ACS infectious diseases 7 (6), 1558-1568, 2021 | 7 | 2021 |
| Lung injury induces a polarized immune response by self-antigen-specific CD4+ Foxp3+ regulatory T cells DS Shin, S Ratnapriya, CN Cashin, LF Kuhn, RA Rahimi, RM Anthony, ... Cell reports 42 (8), 2023 | 6 | 2023 |
| Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens S Ahmed, D Parthasarathy, R Newhall, T Picard, M Aback, S Ratnapriya, ... NPJ vaccines 8 (1), 181, 2023 | 5 | 2023 |
| Broad tricyclic ring inhibitors block SARS-CoV-2 spike function required for viral entry S Ratnapriya, AR Braun, H Cervera Benet, D Carlson, S Ding, ... ACS infectious diseases 8 (10), 2045-2058, 2022 | 5 | 2022 |
| Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies D Parthasarathy, KR Pothula, S Ratnapriya, H Cervera Benet, R Parsons, ... Nature Communications 15 (1), 7334, 2024 | 4 | 2024 |
| Management of visceral leishmaniasis with therapeutic vaccines K Rawat, NK Yadav, S Joshi, S Ratnapriya, AA Sahasrabuddhe, A Dube Vaccine: Development and Therapy, 33-45, 2016 | 4 | 2016 |
| Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis NK Yadav, S Joshi, S Ratnapriya, AA Sahasrabuddhe, A Dube Journal of Microbiology, Immunology and Infection 56 (1), 163-171, 2023 | 3 | 2023 |
| An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with iv immunoglobulin SL Sneed, BB Reese, AFS Laureano, S Ratnapriya, I Fraschilla, ... Journal of Clinical Investigation 134 (4), e172980, 2024 | 1 | 2024 |
